Generics Bulletin

EU Reforms Must Heed Pandemic Lessons

By David Wallace 08 Dec 2020

Reforms set out by the European Commission to better prepare the EU for future health crises must heed key lessons learned from experiences of the COVID-19 pandemic, such as the benefits of digitalization, Medicines for Europe has urged

Topic Coronavirus EU Policy & Regulation

HBW Insight

Lessons Learned: European Self-Care Industry Will Come Out Of Pandemic Stronger

By David Ridley 08 Dec 2020

Europe’s self-care industry has “learned its lessons,” particularly in terms of securing the pharmaceutical ingredient supply chain, and will come out of the coronavirus pandemic stronger, insisted AESGP president Birgit Schuhbauer at the BAH’s High-Level Conference on Future Drug Supply in the European Union.

Topic EU OTC Drugs Coronavirus

Generics Bulletin

EU Reforms Must Heed Pandemic Lessons

By David Wallace 29 Nov 2020

Reforms set out by the European Commission to better prepare the EU for future health crises must heed key lessons learned from experiences of the COVID-19 pandemic, such as the benefits of digitalization, Medicines for Europe has urged.

Topic Coronavirus EU Policy & Regulation

Pink Sheet

EU Countries Test Offering Simultaneous Scientific Advice

By Vibha Sharma 27 Nov 2020

An EU pilot project will assess whether there is sufficient demand from companies to obtain simultaneous scientific advice from EU national competent authorities.

Topic EU Innovation Regulation

Pink Sheet

Desperate Measures: How To Soften The Impact Of No-Deal Brexit

By Ian Schofield 27 Nov 2020

Building more cold chain warehouses, finding alternative sources of medicine supplies, and halting parallel exports to mitigate product shortages. Just some of the ideas for tackling the consequences of a no-deal Brexit scenario put forward by industry representatives at a recent parliamentary committee hearing.

Topic Pharma-Brexit Brexit EU

Medtech Insight

BSI Continues UK CE Marking Operations Until Year End

By Amanda Maxwell 27 Nov 2020

There has been quite a lot of conjecture over whether UK notified bodies would have to cease their CE marking operations on Brexit day, 31 January, or whether they would be able to continue until the end of the EU/UK withdrawal agreement. BSI's Gary Slack explains that BSI, for one, is still open for business. 

Topic EU Brexit

Medtech Insight

Brexit: Medical Supplies Facing ‘Significant Disruption’ At Ports

By Ian Schofield 27 Nov 2020

As negotiators struggle to reach agreement on the future UK/EU relationship following Brexit, suppliers have been warned to expect major hold-ups next year for medical products crossing the English Channel.

Topic EU Brexit

Pink Sheet

BIA Sees Some Hope For Regulatory Alignment After Brexit

By Ian Schofield 27 Nov 2020

Could the UK carry on playing a part in the European Medicines Agency from 2021? Much will depend on the complex negotiations on the future relationship that are expected to kick off in March. 

Topic Brexit EU

Pink Sheet

Brexit: New Rules Will Hit Parallel Trade From UK to EU

By Ian Schofield 23 Nov 2020

From next year, owners of trademarks and other rights in the European Economic Area will be able to prevent the parallel export of medicines from the UK to the EEA. But those owning similar rights in the UK will not be able to stop parallel imports from EEA countries. 

Topic EU Pharma-Brexit Brexit